Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.
Molecular bases for the association of FHR-1 with atypical hemolytic uremic syndrome and other diseases.
复制标题
DOI:
10.1182/blood.2020010069
复制
发表时间:
2021-06-24
期刊:
影响因子:
20.3
通讯作者:
Rodríguez de Córdoba S
中科院分区:
文献类型:
--
作者:
Martin Merinero H;Subías M;Pereda A;Gómez-Rubio E;Juana Lopez L;Fernandez C;Goicoechea de Jorge E;Martin-Santamaria S;Cañada FJ;Rodríguez de Córdoba S
Martin Merinero et al delineate the molecular basis for association of mutant factor H–related protein 1 (FHR-1) with atypical hemolytic uremic syndrome (aHUS) and elucidate the interactions between factor H (CFH) and FHR-1 that regulate complement activation. CFH has a C-terminal domain that binds to cells and an N-terminal domain that facilitates degradation of activated complement. FHR-1 lacks complement-degrading activity and binds poorly to cell membranes; rare mutations allow increased cell surface binding and increase recruitment of complement C3, leading to increases in complement activation and aHUS. aHUS-associated FHR-1 mutants are pathogenic because they acquire capacity to bind sialic acids, which allows C3b-binding competition with FH. The mechanism by which surface-bound FHR-1 promotes complement activation is the binding and attraction of native C3 to the cell surface. Factor H (FH)–related proteins are a group of partly characterized complement proteins thought to promote complement activation by competing with FH in binding to surface-bound C3b. Among them, FH-related protein 1 (FHR-1) is remarkable because of its association with atypical hemolytic uremic syndrome (aHUS) and other important diseases. Using a combination of biochemical, immunological, nuclear magnetic resonance, and computational approaches, we characterized a series of FHR-1 mutants (including 2 associated with aHUS) and unraveled the molecular bases of the so-called deregulation activity of FHR-1. In contrast with FH, FHR-1 lacks the capacity to bind sialic acids, which prevents C3b-binding competition between FH and FHR-1 in host-cell surfaces. aHUS-associated FHR-1 mutants are pathogenic because they have acquired the capacity to bind sialic acids, which increases FHR-1 avidity for surface-bound C3-activated fragments and results in C3b-binding competition with FH. FHR-1 binds to native C3, in addition to C3b, iC3b, and C3dg. This unexpected finding suggests that the mechanism by which surface-bound FHR-1 promotes complement activation is the attraction of native C3 to the cell surface. Although C3b-binding competition with FH is limited to aHUS-associated mutants, all surface-bound FHR-1 promotes complement activation, which is delimited by the FHR-1/FH activity ratio. Our data indicate that FHR-1 deregulation activity is important to sustain complement activation and C3 deposition at complement-activating surfaces. They also support that abnormally elevated FHR-1/FH activity ratios would perpetuate pathological complement dysregulation at complement-activating surfaces, which may explain the association of FHR-1 quantitative variations with diseases.
登录
查看更多内容
DOI:
10.4049/jimmunol.0804031
发表时间:
2009-06-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Ferreira VP;Herbert AP;Cortés C;McKee KA;Blaum BS;Esswein ST;Uhrín D;Barlow PN;Pangburn MK;Kavanagh D
通讯作者:
Kavanagh D
影响因子:
13.6
作者:
de Jorge, Elena Goicoechea;Tortajada, Agustin;de Cordoba, Santiago Rodriguez
通讯作者:
de Cordoba, Santiago Rodriguez
影响因子:
15.9
作者:
Tortajada, Agustin;Yebenes, Hugo;Rodriguez de Cordoba, Santiago
通讯作者:
Rodriguez de Cordoba, Santiago
影响因子:
8.6
作者:
Närkiö-Mäkelä, M;Hellwage, J;Meri, S
通讯作者:
Meri, S
影响因子:
4.3
作者:
Schmidt CQ;Hipgrave Ederveen AL;Harder MJ;Wuhrer M;Stehle T;Blaum BS
通讯作者:
Blaum BS